# Doppler Evaluation in RA Patients After Adalimumab.

> **NCT01609205** · PHASE4 · COMPLETED · sponsor: **Hamed Rezaei** · enrollment: 60 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Adalimumab

## Key facts

- **NCT ID:** NCT01609205
- **Lead sponsor:** Hamed Rezaei
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609205, "Doppler Evaluation in RA Patients After Adalimumab.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01609205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*